Company Financials: Orthopaedics and Spine

• Posted in Business Critical | December 13, 2011 | Comments (0)
• Tags: supplier, industry watch, vetalice, earnings, financial, market growth, company financials, sales, oem, big picture, market, earning, Financials
• By: Julie A. Vetalice

ORTHOWORLD estimates place overall market growth at 5% over 3Q10, as shown in Exhibit 1, which displays orthopaedic sales growth by product segment. Performance highlights follow, and relate to 3Q unless otherwise noted.

Exhibit 1: Orthopaedic Sales Increases¹ by Product Segment: 3Q11 vs. 3Q10 

Notes to Exhibit 1
¹ Orthopaedic products only; constant currency, pro forma growth
² Includes biologics
³ For the quarter ended 8/31/11; Spine includes Bone Stim and Biologics; Bone Stim reflects all Bone Healing sales.
⁴ For the quarter ended 10/28/11
⁵ Spine
⁶ For the quarter ended 9/30/11
⁷ Extremities: extremities + fixation combined; Endoscopy: endoscopic + communications, most of which is orthopaedic; Spine: neuro + spine. Total growth excludes Patient Handling.
⁸ ORTHOWORLD estimates
⁹ Excludes "Other" (Aerospace)